Dr. Alan Liss has over 30 years of experience in vaccine, biologic, and pharmaceutical product development and manufacturing.
Dr. Liss recently retired from the Food and Drug Administration where he directed the Public Health and Security Action Team Program which enhanced the FDA approval process for medical countermeasure candidates. Prior to joining the FDA, Dr. Liss helped stand up the Regulatory and Quality Affairs Division of the Biomedical Advanced Research and Development Authority (BARDA). Prior to joining the government, Dr. Liss designed and executed effective U.S. global quality and regulatory strategies to support both pharmaceutical and biopharmaceutical development programs.
Dr. Liss received his B.S. in Genetics from the University of California, Berkeley and his Ph.D. in Microbiology and Immunology from the University of Rochester.